$XNET

Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2024

SHENZHEN, China, April 25, 2025 ( GLOBE NEWSWIRE ) -- Xunlei Limited ( "Xunlei" or the "Company" ) ( NASDAQ: XNET ) , a leading technology company providing distributed cloud services in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, ...

Original reporting
GlobeNewswire · Xunlei Limited
Published Apr 25, 2025, 2:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 25, 2025, 3:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2024 — source image
Decision brief

The 30-second read

$XNETBullishMed
01

Why it matters

The filing enhances transparency and may boost investor confidence, potentially leading to short-term stock appreciation.

02

Market read

The news is relevant for investors interested in Chinese tech and cloud service sectors, with immediate implications for Xunlei Limited's stock performance.

03

What to watch

Potential regulatory changes or market conditions in China that could offset positive signals from the report.

Timing: Immediate, as the news was published today.

Background

Xunlei Limited is a leading provider of distributed cloud services in China, with a focus on technology innovation.

Company-level read

Ticker impact

$XNETBullishHigh confidence
Context

Primary focus of the news, as Xunlei Limited filed its annual report.

Expected impact

Moderate upward movement in stock price over the short to medium term.

Evidence & confidence

The company's proactive disclosure suggests stability and adherence to regulatory requirements, which are viewed favorably by investors.

Market effects

Potential positive sentiment in the Chinese technology and cloud services sector.

Limited, primarily affecting investors and stakeholders in China.

Low, as the news is company-specific and not indicative of broader global trends.

Counterpoint

Some investors may view the filing as routine and not indicative of future performance, suggesting caution.

Key entities

  • Xunlei Limited

    A Chinese technology company specializing in distributed cloud services.

Related articles

$XNETMedAI 8/10

Xunlei (XNET) Q2 2026 Earnings Call Transcript

Xunlei (XNET) reported Q2 2026 results in an earnings call transcript. Total revenue rose to $102.7 million, up 38.9% year over year, driven by subscription revenue of $44.5 million (+22.6%) and overseas audio live streaming revenue of $58.2 million (+54.8%). Gross margin fell to 55.8% from 63%. The company announced a $20 million share repurchase program.

$XNETMedAI 8/10

Xunlei Limited: Xunlei Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2026

Xunlei Limited (Nasdaq: XNET) reported unaudited Q2 2026 results for the quarter ended June 30, 2026. Total revenues were $102.7M (+38.9% YoY), with subscription $44.5M (+22.6%) and live-streaming/other $58.2M (+54.8%). Gross profit was $57.3M (margin 55.8% vs 63.0%). Net loss from continuing ops was $218.5M ($3.43 loss per ADS); non-GAAP net loss was $2.1M. The company also announced a new share repurchase program.

$XNETMedAI 9/10

Xunlei Announces Unaudited Financial Results for the First Quarter Ended March 31, 2026

Xunlei Limited (Nasdaq: XNET) reported unaudited Q1 2026 results for the quarter ended March 31, 2026. Total revenue rose 54.1% YoY to $98.6m, driven by subscription ($45.0m, +26.2%) and overseas audio live-streaming ($53.6m, +89.3%). Gross profit increased to $57.7m, but margin fell to 58.5%. Net loss from continuing operations was $192.4m; non-GAAP net income was $4.1m.

$HNGEMed

Jim Cramer says one stock hitting new highs is still a screaming buy

Jim Cramer reiterated a triple buy call on Hinge Health (HNGE) on “Mad Money” Aug. 11. The stock hit a new all-time high of $93.13 on Aug. 10 and is up about 85.83% YTD, per Yahoo Finance. Hinge reported Q2 2026 revenue of $213 million (+53% YoY), free cash flow of $99.6 million, and raised FY guidance to $856-$860 million. It also agreed to a $105 million cash acquisition (Cylinder Health) to expand into GI care.

Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2024 — alphai